DavidE.CohnMD

PubMed

• Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
  Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Iof...> ;J. Natl. Cancer Inst.. 2017-03-01
• Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists.
  Crafton SM, Lynch CD, Cohn DE, Eisenhauer EL> ;Gynecol Oncol Rep. 2017-02-01
• Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine.
  Cohn, D. E.,Backes, F. J.,Wallbillich, J. J.,Bixel, K.,Crafton, S. M.,Neff, R.,ElNaggar, A. C.,Smith, B.,Suarez, A. A.> ;Gynecol. Oncol.. 2017 Feb 06
• Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
  Koh W, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgin...> ;J Natl Compr Canc Netw. 2017-01-01
• A Phase I Trial of Paclitaxel, Cisplatin and Veliparib in the Treatment of Persistent or Recurrent Carcinoma of the Cervix: An NRG Oncology Study (NCT#01281852).
  Thaker PH, Salani R, Brady WE, Lankes HA, Cohn DE, Mutch DG, Mannel RS, Bell-McGuinn KM, DiSilvestro PA, Jelovac D, Carter JS, Duan W, Resnick KE, Dizon DS, Aghajanian...> ;Ann. Oncol.. 2016-12-19
• Bokhman Redux: Endometrial cancer "types" in the 21st century.
  Suarez AA, Felix AS, Cohn DE> ;Gynecol. Oncol.. 2016-12-16
• Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic On...
  Garcia-Soto AE, Java JJ, Nieves Neira W, Pearson JM, Cohn DE, Lele SB, Tewari KS, Walker JL, Alvarez Secord A, Armstrong DK, Copeland LJ> ;Gynecol. Oncol.. 2016-12-01
• Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
  Smith B, McCann GA, Phillips G, Backes FJ, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R> ;Gynecol. Oncol.. 2016-11-21
• Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort.
  Backes FJ, ElNaggar AC, Farrell MR, Brudie LA, Ahmad S, Salani R, Cohn DE, Holloway RW, Fowler JM, O'Malley DM> ;Int. J. Gynecol. Cancer. 2016-11-01
• Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
  Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Mall...> ;JAMA Oncol. 2016-11-01
• The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.
  Smith B, Neff R, Cohn DE, Backes FJ, Suarez AA, Mutch DG, Rush CM, Walker CJ, Goodfellow PJ> ;Gynecol. Oncol.. 2016-11-01
• High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.
  Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME> ;Int. J. Cancer. 2016-10-14
• The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcin...
  Joehlin-Price AS, McHugh KE, Stephens JA, Li Z, Backes FJ, Cohn DE, Cohen DW, Suarez AA> ;Am. J. Surg. Pathol.. 2016-10-12
• Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
  McMeekin DS, Tritchler DL, Cohn DE, Mutch DG, Lankes HA, Geller MA, Powell MA, Backes FJ, Landrum LM, Zaino R, Broaddus RD, Ramirez N, Gao F, Ali S, Darcy KM, Pearl ML...> ;J. Clin. Oncol.. 2016-09-01
• Aspirin and endometrial cancer risk.
  Brasky TM, Cohn DE, Bernardo BM> ;Gynecol Oncol Rep. 2016-08-01
• A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy.
  Wallbillich JJ, Forde B, Havrilesky LJ, Cohn DE> ;Gynecol. Oncol.. 2016-07-01
• The biological significance and clinical applications of exosomes in ovarian cancer.
  Dorayappan KDP, Wallbillich JJ, Cohn DE, Selvendiran K> ;Gynecol. Oncol.. 2016-07-01
• Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
  Saini U, Naidu S, ElNaggar AC, Bid HK, Wallbillich JJ, Bixel K, Bolyard C, Suarez AA, Kaur B, Kuppusamy P, Hays J, Goodfellow PJ, Cohn DE, Selvendiran K> ;Oncogene. 2016-06-13
• Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence: A Subanalysis.
  Billingsley CC, Cohn DE, Mutch DG, Hade EM, Goodfellow PJ> ;Int. J. Gynecol. Cancer. 2016-06-01
• Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.
  Backes FJ, Walker CJ, Goodfellow PJ, Hade EM, Agarwal G, Mutch D, Cohn DE, Suarez AA> ;Gynecol. Oncol.. 2016-05-01
• Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and Prognosis.
  Joehlin-Price AS, Stephens JA, Zhang J, Backes FJ, Cohn DE, Suarez AA> ;Cancer Epidemiol. Biomarkers Prev.. 2016-03-01
• Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
  Billingsley CC, Cansino C, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Backes FJ, Salani R> ;Gynecol. Oncol.. 2016-03-01
• A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging o...
  Cohn DE, Castellon-Larios K, Huffman L, Salani R, Fowler JM, Copeland LJ, O'Malley DM, Backes FJ, Eisenhauer EL, Abdel-Rasoul M, Puente EG, Bergese SD> ;J Minim Invasive Gynecol. 2016-01-01
• Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation.
  Crafton S, Nekkanti S, Lynch C, Cohn DE, Fowler JM, Copeland LJ, O'Malley DM, Salani R, Backes FJ, Eisenhauer EL> ;Int. J. Gynecol. Cancer. 2016-01-01
• Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectives.
  Lee J, Kwon JS, Cohn DE, Kim Y, Smith B, Lee T, Kim J> ;Gynecol. Oncol.. 2016-01-01
• Join now to see all